PT Indofarma Tbk (IDX:INAF)
Indonesia · Delayed Price · Currency is IDR 126.00
0.00 (0.00%)
Jul 1, 2024, 2:55 PM WIB
PT Indofarma Tbk Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 151,551 | 210,380 | 523,599 | 980,371 | 2,901,987 | |
Revenue Growth (YoY) | -27.96% | -59.82% | -46.59% | -66.22% | 69.15% |
Cost of Revenue | 170,856 | 252,481 | 682,495 | 995,673 | 2,459,112 |
Gross Profit | -19,305 | -42,102 | -158,896 | -15,302 | 442,875 |
Selling, General & Admin | 102,245 | 226,251 | 221,512 | 266,372 | 292,788 |
Other Operating Expenses | 80,243 | -18,416 | 186,450 | 56,407 | 96,867 |
Operating Expenses | 182,488 | 207,835 | 407,963 | 322,780 | 389,656 |
Operating Income | -201,793 | -249,937 | -566,859 | -338,082 | 53,219 |
Interest Expense | -23,606 | -30,011 | -59,159 | -38,081 | -42,957 |
Interest & Investment Income | 91.51 | 105.92 | 5,562 | 2,922 | 1,841 |
Earnings From Equity Investments | 467.1 | 512.13 | 392.24 | 85.28 | 99.66 |
Currency Exchange Gain (Loss) | -4,943 | -3,743 | 1,211 | -10,097 | -1,697 |
Other Non Operating Income (Expenses) | - | -527.07 | -1,330 | -18 | -348.95 |
EBT Excluding Unusual Items | -229,783 | -283,600 | -620,183 | -383,270 | 10,158 |
Gain (Loss) on Sale of Investments | - | -155 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | 260.9 | -901.45 | - |
Asset Writedown | - | - | -43,636 | -2,592 | -1,384 |
Other Unusual Items | 158,328 | -3.03 | -5,952 | -162,572 | - |
Pretax Income | -71,455 | -283,758 | -669,509 | -549,336 | 8,773 |
Income Tax Expense | 6,534 | 50,734 | 51,491 | -91,687 | 46,344 |
Earnings From Continuing Operations | -77,989 | -334,492 | -721,000 | -457,649 | -37,571 |
Minority Interest in Earnings | - | 3.61 | 6.9 | 25.01 | -9.4 |
Net Income | -77,989 | -334,489 | -720,993 | -457,624 | -37,581 |
Net Income to Common | -77,989 | -334,489 | -720,993 | -457,624 | -37,581 |
Shares Outstanding (Basic) | 3,099 | 3,099 | 3,099 | 3,099 | 3,099 |
Shares Outstanding (Diluted) | 3,099 | 3,099 | 3,099 | 3,099 | 3,099 |
Shares Change (YoY) | - | - | - | - | 12.37% |
EPS (Basic) | -25.16 | -107.93 | -232.63 | -147.66 | -12.13 |
EPS (Diluted) | -25.16 | -107.93 | -232.63 | -147.66 | -12.13 |
Free Cash Flow | -209,982 | -21,704 | -198,869 | -88,414 | 71,629 |
Free Cash Flow Per Share | -67.75 | -7.00 | -64.17 | -28.53 | 23.11 |
Gross Margin | -12.74% | -20.01% | -30.35% | -1.56% | 15.26% |
Operating Margin | -133.15% | -118.80% | -108.26% | -34.48% | 1.83% |
Profit Margin | -51.46% | -158.99% | -137.70% | -46.68% | -1.29% |
Free Cash Flow Margin | -138.56% | -10.32% | -37.98% | -9.02% | 2.47% |
EBITDA | -188,675 | -232,761 | -545,223 | -314,604 | 77,844 |
EBITDA Margin | -124.50% | -110.64% | -104.13% | -32.09% | 2.68% |
D&A For EBITDA | 13,118 | 17,176 | 21,636 | 23,477 | 24,625 |
EBIT | -201,793 | -249,937 | -566,859 | -338,082 | 53,219 |
EBIT Margin | -133.15% | -118.80% | -108.26% | -34.48% | 1.83% |
Effective Tax Rate | - | - | - | - | 528.25% |